Industry Sounds Somewhat Muted Drug Pricing Alarm

Pharma CEOs expect the US pricing situation will remain stable in the near-term but accept drug prices will continue to face pressure and agree that the future remains uncertain. Subsiding rhetoric after elections may bring some relief.